We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Orders Psychiatric Warn Labels On Asthma Drugs

Law360 (June 12, 2009, 12:00 AM EDT) -- The U.S. Food and Drug Administration has asked AstraZeneca Pharmaceuticals LP, Merck & Co. Inc. and Cornerstone Therapeutics Inc. to update the labeling for their leukotriene modifiers class of asthma drugs...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.